How can CV outcomes trials in T2D guide clinical practice?
An expert panel offers practical insights.
An expert panel offers practical insights.
Handy infographic for navigating the changing treatment landscapeÂ
A digital event dedicated to the General Practice Owner Community, where experts in their chosen fields will share knowledge on the latest trends & tools to…
A Q&A with Associate Professor Deborah Bateson
Neurologist shares best practice diagnosis and management techniques
Watch this useful refresher on best practice assessment and treatment
Aortic stenosis is a life-threatening valvular heart disease, characterised by progressive narrowing of the aortic valve. In this quick-fire Q&A, interventional cardiologist Associate Professor Sonny Palmer,…
6 reasons to consider glucagon-like peptide-1 receptor agonists (GLP-1RA) as second-line therapy
Research reveals treatment non-adherence is partly to blame
As a GP you are the primary source of care for patients with type 2 diabetes (T2D). But this disease can be a challenging one…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.